Literature DB >> 6800757

New antiarrhythmic drugs: their place in therapy.

D L Keefe, R E Kates, D C Harrison.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6800757     DOI： 10.2165/00003495-198122050-00002

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  198 in total

1.  THE SYMPATHOMIMETIC ACTION OF BRETYLIUM OF ISOLATED ATRIA AND AORTIC SMOOTH MUSCLE.

Authors:  S M KIRPEKAR; R F FURCHGOTT
Journal:  J Pharmacol Exp Ther       Date:  1964-01       Impact factor: 4.030

2.  Disopyramide.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1979-04-26       Impact factor: 91.245

3.  A peculiar cutaneous pigmentation from cordarone.

Authors:  A K Vos; A G van Ramshorst; J C Grosfeld; J P Goossens
Journal:  Dermatologica       Date:  1972

4.  Drugs and the heart. IV. Antiarrhythmic agents.

Authors:  L H Opie
Journal:  Lancet       Date:  1980-04-19       Impact factor: 79.321

5.  Antiarrhythmic efficacy of encainide and quinidine: validation of a model for drug assessment.

Authors:  M Sami; D C Harrison; H Kraemer; N Houston; C Shimasaki; R F DeBusk
Journal:  Am J Cardiol       Date:  1981-07       Impact factor: 2.778

6.  Influence of moxaprindine treatment on ventricular arrhythmias occurring during maximal exercise stress testing.

Authors:  H Kesteloot; F van de Werf; B Marchandise; R Sluyts
Journal:  Acta Cardiol       Date:  1979       Impact factor: 1.718

7.  Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation.

Authors:  D H Bennett
Journal:  Chest       Date:  1978-12       Impact factor: 9.410

8.  Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes.

Authors:  P J Podrid; A Lyakishev; B Lown; N Mazur
Journal:  Circulation       Date:  1980-02       Impact factor: 29.690

9.  Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.

Authors:  D M Roden; S B Reele; S B Higgins; G R Wilkinson; R F Smith; J A Oates; R L Woosley
Journal:  Am J Cardiol       Date:  1980-09       Impact factor: 2.778

10.  Open clinical studies at a referral center: chronic maintenance tocainide therapy in patients with recurrent sustained ventricular tachycardia refractory to conventional antiarrhythmic agents.

Authors:  J D Maloney; R G Nissen; J M McColgan
Journal:  Am Heart J       Date:  1980-12       Impact factor: 4.749
View more
  13 in total

1.  Effects of encainide on the inducibility of ventricular arrhythmia in normal anesthetized dogs.

Authors:  F D Zeng; S Nattel
Journal:  J Tongji Med Univ       Date:  1986

2.  Current classification of antiarrhythmic drugs as a guide to their rational clinical use.

Authors:  D C Harrison
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

Review 3.  Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.

Authors:  K A Muhiddin; P Turner
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

4.  A rational scientific basis for subclassification of antiarrhythmic drugs.

Authors:  D C Harrison
Journal:  Trans Am Clin Climatol Assoc       Date:  1986

5.  Kinetics of oral and intravenous mexiletine: lack of effect of cimetidine and ranitidine.

Authors:  N H Brockmeyer; H Breithaupt; W Ferdinand; M von Hattingberg; E E Ohnhaus
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics of bretylium.

Authors:  W G Rapeport
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

7.  Tricyclic antidepressant poisoning. Management of arrhythmias.

Authors:  P R Pentel; N L Benowitz
Journal:  Med Toxicol       Date:  1986 Mar-Apr

8.  Ajmaline test in a patient with chronic renal failure. A pharmacokinetic and pharmacodynamic study.

Authors:  R Padrini; L Compostella; D Piovan; A Javarnaro; F Cucchini; M Ferrari
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

9.  Antiarrhythmic drugs and polyneuropathy. The Collaborative Group for the Study of Polyneuropathy.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

Review 10.  New antiarrhythmic drugs.

Authors:  P F Nestico; J Morganroth; L N Horowitz
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.